[This review was originally posted at the Nieman Journalism Lab Order Synthroid, on June 1, 2012.]
Debating the meaning of Facebook’s IPO flop: Facebook’s fall following its initial public offering two weeks ago continued this week, with shares dropping under $30 (they were initially offered at $38). Several other social media-based companies have seen their stock tank, too, prompting Forbes’ Dee Gill to wonder if Facebook’s IPO has been a reminder that “even a wildly popular product won’t save a company that can’t make money.”
David Strom of ReadWriteWeb did point out, though, that stock prices soon after tech IPOs haven’t been a very reliable indicator of companies’ prospects for long-term success. The New York Times’ Joe Nocera made a similar point, arguing that Facebook’s IPO flop was fueled by get-rich-quick investors and that long-term investors should be undeterred, Synthroid treatment.
At PandoDaily, Farhad Manjoo made the case that Facebook’s IPO was a valuable corrective to a dangerously overhyped tech market: “Facebook’s IPO proves that there isn’t an endless supply of bigger suckers. And because bigger suckers are the primary ingredients in bubbles, it now seems likely that the new tech bubble—if there ever was one—is dead, dead, dead.” And The Atlantic’s Alexis Madrigal made a pretty thorough defense of Facebook’s value as a company, Synthroid forum, reminding us that it has a still-growing near-monopoly and tremendous potential for making money from its millions of users.
There was still plenty of criticism of Facebook floating around this week, though, Order Synthroid. The New York Times’ Ross Douthat saw Facebook as a sign of the lack of financial progress brought by the Internet economy, and Facebook’s advertising shortcomings continued to be a point of discussion. Ad Age reported that GM pulled its advertising from Facebook in part because Facebook balked at its proposal to run full-page ads, which, according to media consultant Terry Heaton, illustrated the difference between Madison Avenue’s philosophy of bending the masses to their will and Facebook’s gentler approach. The Huffington Post’s Bianca Bosker also looked at the tension Facebook is facing between its advertisers and users, Synthroid maximum dosage.
Here at the Lab, Dan Kennedy extended the ad problem to journalists, proposing a few ideas for adapting to an online world in which the value of ads continues to shrink. Order Synthroid, Also on the news front, Buzzfeed’s John Herrman wrote about how coverage on Twitter of the Facebook IPO indicates that Twitter is well ahead of Facebook in covering and developing breaking stories.
Another major note on Facebook to keep an eye on: The New York Timesreported that the company is trying again to build a smartphone to release later this year. It’s had several false starts in this area before, but is moving “deeper into the process” this time. Is Synthroid addictive, Facebook was also reported this week to be buying the facial recognition company Face.com.
The impact of New Orleans’ move away from print: As we moved into the second week of discussion of the New Orleans Times-Picayune’s cutback from daily newspaper production, the conversation began to shift from New Orleans in particular to the future of the newspaper industry as a whole. Poynter’s Steve Myers looked at a couple of the immediate issues — concerns over whether Advance Publications’ other papers (such as the Cleveland Plain Dealer) might make similar cuts, and whether New Orleans readers are likely to follow their paper online, Order Synthroid.
The New York Times’ David Carr, who broke the story, wrote a kind of elegy for the paper, concluding that while the cutback may make some financial sense, it’s a great loss for a historically corrupt city. “The constancy of a paper, ordering Synthroid online,” he wrote, “is a reminder to a city that someone is out there watching.” At the Huffington Post, Harry Shearer thought Carr wasn’t harsh enough in his assessment of Advance’s plans, arguing that breaking readers’ daily newspaper habits is foolish, not economical. Shearer, Synthroid wiki, Myers, and Iowa journalist Dave Schwartz all pointed out that New Orleans has particularly low Internet penetration rates (not to mention high newspaper penetration rates), with Schwartz calling those without web access “casualties in a revolution.”
Mathew Ingram of GigaOM and CUNY prof Jeff Jarvis, on the other hand, both argued that we need to get past our fixation with print journalism, using it when it’s profitable but feeling free to drop it when it’s not. “We have to make print beside the point,” Jarvis wrote, Synthroid without prescription. Will Bunch of the Philadelphia Daily News, meanwhile, proposed some ideas at Poynter for resolving the journalism crisis in New Orleans, focusing on philanthropic efforts to improve Internet access, hyperlocal journalism, and accountability journalism. Al Jazeera discussed the future of the newspaper industry Order Synthroid, in light of New Orleans’ move away from daily with a few luminaries as well. Synthroid dangers,
While Postmedia CEO Paul Godfrey complained in an interview with the Globe & Mail that its ad revenue was being stolen by foreign digital companies (read: Google, AOL, etc.), GigaOM’s Mathew Ingram said the problems for Postmedia and other newspapers run much deeper than cuts and paywalls. Synthroid street price, Crain’s Chicago Business also reported that the Chicago Tribune is considering a paywall potentially focusing on niche coverage, and Poynter’s Steve Myers pointed out that the major newspaper companies that aren’t charging for news are quickly becoming the outliers.
The paywall debate got a shot in the arm this week in the aftermath of the Times-Picayune’s cuts, when The Wire creator and former newspaper reporter David Simon asserted at the Columbia Journalism Review that “the whole industry will continue to collapse until everyone swallows hard and goes behind a paywall.”The short post spurred a feisty comment thread as well as several varying responses, Order Synthroid. A post at the news startup Circa made a distinction between charging for content (OK) and information (much more difficult to do), and Will Bunch made his aforementioned philanthropically driven proposals for New Orleans as a middle way between paywall advocates and detractors.
In addition, former newspaper editor John L. Robinson argued that if young people won’t even pay much for Facebook, they sure won’t pay for a newspaper — and that should worry newspaper publishers, Synthroid class. Here at the Lab, Ken Doctor added some practical approaches to the discussion, looking at the effectiveness of different newspapers’ plans to shift from advertiser revenue toward reader revenue.
Mathew Ingram of GigaOM echoed the idea, and meanwhile, Technically Philly’s Sean Blanda and blogger Dave Winer both wrote on rethinking the elements of an article — Blanda proposed thinking of the basic unit of journalism as the fact rather than the article, and Winer said we need to do better than Wikipedia when it comes to background information and explainers, Order Synthroid.
— WikiLeaks’ Julian Assange lost his appeal to the British Supreme Court against extradition to Sweden on accusations of a pair of 2010 sexual abuse cases. No prescription Synthroid online, He has two weeks to appeal one of the ruling’s points, but it looks as though he’s headed to Sweden to stand trial. Here’s The Guardian’s and The New York Times’ coverage, and Micah Sifry’s examination of the state of online whistleblowing as WikiLeaks struggles.
— A couple of ebook notes: Amazon settled its dispute Order Synthroid, with a publisher that pulled its books from the site earlier this year, and meanwhile, two other publishers filed responses to the Department of Justice’s antitrust suit on ebook pricing, and Apple filed its response to a parallel class-action suit.
— Web designer Oliver Reichenstein ripped the ubiquitous “Share” buttons all over news and other sites, while the Lab’s Joshua Benton provided some initial data showing they may be quite helpful for news orgs to prompt sharing of their content on Twitter.
— Cornell prof Tarleton Gillespie wrote an interesting post exploring whether we can trust Twitter’s Trending Topics algorithm, and GigaOM’s Mathew Ingram said it’s not necessarily Twitter’s job to broaden our worldview, Synthroid dose, but instead our own responsibility.
— Finally, it’s not shameless self-promotion if it’s actually really good: The Lab ran several fascinating pieces this week that are worth a look — Justin Ellis’ talk with Guardian editor Alan Rusbridger, some cool ideas for improving news from MIT Media Lab students courtesy of Andrew Phelps, and the AP’s Jonathan Stray’s smart column on broadening our concept of what journalists do. Enjoy.
Similar posts: Tramadol Cost. Glucophage Over The Counter. Diflucan Dosage. Bactrim price. Tramadol without a prescription. Tramadol overnight.
Trackbacks from: Order Synthroid. Order Synthroid. Order Synthroid. Buy Synthroid online cod. Synthroid pharmacy. Is Synthroid safe.
[This review was originally posted at the Nieman Journalism Lab Cephalexin Dosage, on May 25, 2012.]
Facebook’s quick fall: A week ago, Facebook had just launched the largest, most buzzworthy initial public offering in years. And now, that IPO has already brought them a potentially massive lawsuit and a federal investigation. Aside from the whole “pocketing millions upon millions of dollars” thing, it’s been a brutal week for Facebook execs. Here’s what happened.
Facebook dominated the conversation online last week (GigaOM has a good roundup from last Friday’s IPO), and a lot of that wasn’t positive, kjøpe Cephalexin på nett, köpa Cephalexin online. As data from Pew’s Project for Excellence in Journalism showed, much of the chatter online, particularly on Twitter, was about Facebook as an overhyped (and overvalued) stock, Cephalexin Dosage. Those online observers may have been more right than they knew: As reports from Reuters, Business Insider (two posts), and The Wall Street Journaldetailed, Facebook was allegedly telling top investors they had overestimated their projected financial figures, all while publicly talking up their earning potential and even expanding their stock offering to the rest of us. The result, My Cephalexin experience, so far, has been a U.S. Securities and Exchange Commission investigation and a (potentially class-action) lawsuit from investors.
There were a number of good analyses of what went wrong — at The Guardian, Heidi Moore laid out the list of sins involved and concluded, “Facebook didn’t know how to work its own privacy settings for investors. It couldn’t figure out, essentially, who should know what.” Reuters’ Felix Salmon was more specific with his list of incompetents, Cephalexin for sale, declaring that the only winners in this game were the ones who didn’t play at all. The Big Picture’s Barry Ritholtz also ripped apart the debacle Cephalexin Dosage, .
The whole scandal still leaves open the question of what Facebook should, in fact, be valued at. At Technology Review, Michael Wolff was most provocative with his assessment, Cephalexin without a prescription, arguing that Facebook is just another business inextricably reliant on a fatally flawed online advertising model: “The crash will come. And Facebook—that putative transformer of worlds, which is, in reality, only an ad-driven site—will fall with everybody else,” he wrote. Harvard’s Doc Searls echoed Wolff’s thoughts about the brokenness of Facebook’s (and the web’s) ad model, and media consultant Terry Heaton countered that the broken industry isn’t the ad-supported web, Cephalexin reviews, but Madison Avenue’s insistence on the status quo on that web.
Others looked more closely at the future of Facebook’s services and of the social web more generally, Cephalexin Dosage. The Atlantic’s Alexis Madrigal wondered whether Facebook’s users would keep sharing and what would become of its native and mobile users, and ReadWriteWeb’s Dan Frommer examined the company’s four biggest risks (there’s mobile and advertising again!). There were other problems spotted: All Things D’s Peter Kafka looked at the continued decline of Facebook’s Social Reader apps, and The New York Times’ Nick Bilton contrasted Facebook and Twitter’s approaches to privacy. Tech blogger Dave Winer insisted that we can do better than Facebook, What is Cephalexin, while Slate’s Farhad Manjoo contended that Facebook has improved Silicon Valley.
The end of an era for New Orleans news: The American newspaper industry absorbed another big blow this week when the New Orleans Times-Picayune announced that it would drop back from daily publication to just three days a week, a change accompanied by the creation of a new corporate entity to run the paper and heavy layoffs — possibly a third of the newsroom. Cephalexin Dosage, The change will leave New Orleans as the largest city in the U.S. without a daily newspaper.
The news was broken by The New York Times’ David Carr, and according to the New Orleans alt-weekly Gambit, Times-Picayune employees learned of the paper’s fate through his report. (They later got this memo from the paper’s publisher.) All this came despite the fact that, Cephalexin schedule, as Jim Romenesko reported, the paper remains profitable. For some of the background on the paper — which is owned by Advance Publications, a division of the Newhouse publishing empire — see this post at the Columbia Journalism Review. (Advance also announced they’d be doing the same thing with three of its Alabama papers, led by the Birmingham News.)
Media analyst Ken Doctor has an extremely useful analysis of what exactly Advance/Newhouse is trying to accomplish with this move, and what perils it faces, Cephalexin Dosage. Doctor called the paper’s transition to digital a “forced march” because the paper simply isn’t ready for a digital transformation, particularly in terms of digital circulation. Purchase Cephalexin online, Others were similarly skeptical: The immediate comparison was to Advance’s 2009 transition of the daily Ann Arbor News to AnnArbor.com, and Forbes’ Micheline Maynard gave a bleak picture of what’s left of that news organization and the hole it’s left in the community.
Forbes’ John McQuaid, a former Times-Picayune reporter, described the way Advance’s web strategy has been “only lightly tethered to newsgathering,” and concluded that “with Advance, news has always been an adjunct to its vanilla branded sites, not something that is driving the internal business conversation, Cephalexin samples, and it shows.” And former Wall Street Journal writer (and Times-Picayune intern) Jason Fry said he doesn’t see any reason for optimism that Advance will get the web right in this case.
Free Press’ Josh Stearns noted that while the future-of-news world has been optimistically focused on experiments to sustain quality journalism in certain hubs like San Francisco, Chicago, and New York, they need to pay closer attention to mid-sized cities like New Orleans, where the infrastructure simply isn’t there to pick up the journalism being cut at major traditional news organizations.
What’s behind Buffett’s newspaper buy?: I briefly mentioned Warren Buffett’s purchase Cephalexin Dosage, late last week of 63 newspapers from Media General in last week’s review, but some smart commentary has come out about the deal since then (along with a few other pieces I missed at the time), so it’s worth touching on again. Cephalexin long term, Media analyst Ken Doctor did a sharp rundown of the deal, pointing out that the upside of Media General’s broadcast properties and the real estate involved with the newspapers Buffett’s buying should help buffer him from the inherent danger of buying a set of newspapers. Reuters’ Jack Shafer pointed out several of Buffett’s past bearish statements about newspapers, but said he’s most likely buying because he sees an undervalued asset, not for any sentimental reason.
The Columbia Journalism Review’s Justin Peters and The Washington Post’s Erik Wemple both explained why these papers might be surprisingly valuable for Buffett: While major metro dailies have taken a beating, smaller community newspapers in rural areas have weathered the digital storm fairly well so far, in part because of their monopoly on local news and the slower rates of broadband adoption there, online buy Cephalexin without a prescription.
Former journalism professor Philip Meyer made a similar point, arguing that Buffett is the type of buyer who’s happy with the new normal of lower profit margins for newspapers: “It looks like he is betting that the slide in newspaper earning power has leveled out. The Internet has done all the damage it can, and papers still make money.” PaidContent’s Jeff John Roberts looked at the economic sense Buffett’s paywall plan makes, while media consultant Dan Conover said he should be open to other non-paywall-based models, Cephalexin Dosage. Poynter’s Andrew Beaujon, meanwhile, said we may be ignoring another big reason for news org purchases like Buffett’s — they’re a platform for personal philosophies of how journalism should be done. Buffett did tell his new papers’ publishers that he would be hands-off with them, Cephalexin dosage, and that he expected to buy more small and mid-sized papers.
The bill, which was supposedly meant as a weapon against cyber-bullying and attacks against “local businesses and elected officials,” was predictably (and rightly) met with derision from scholars and those on the web. Columbia’s Tim Wu told The Guardian the bill was “an obvious first amendment violation, Cephalexin blogs,” and the bill was also ripped at sites like Techdirt and Animal. BetaBeat reported that some of the lawmakers involved with the bill were surprised by the blowback about it, while The Atlantic brought out a dissenting opinion, with a point/counterpoint on the value of anonymous online discourse.
— The Wall Street Journal reported on some of the ongoing struggles with AOL’s hyperlocal journalism project, Patch, Comprar en línea Cephalexin, comprar Cephalexin baratos, breaking the news that 20 Patch employees were being laid off and that one of AOL’s major investors is trying to get Patch killed, sold, or put into a joint venture. Jeff Bercovici of Forbes said it’s going to take a lot more cost-cutting or revenue-raising to get Patch to profitability by next year, and The Washington Post’s Erik Wemple said hyperlocal journalism’s business model doesn’t have room for executives in suits, Cephalexin Dosage.
— The New York Times’ public editor, Arthur Brisbane, will leave his position in September after two years, declining an optional third year. The Washington Post’s Erik Wemple, Cephalexin from canadian pharmacy, who broke the story, took the opportunity to criticize his most recent column, and Poynter’s Craig Silverman proposed five qualifications for the next public editor of the Times. Poynter also held a chat about the role of ombudsmen with Washington Post ombudsman Patrick Pexton and Reuters’ Jack Shafer.
— This week in Murdoch was a relatively quiet one. Cephalexin Dosage, News Corp. was reported to be considering spinning off its British newspapers — the Sun, the Times, and the Sunday Times — in order to preserve the rest of its media empire, something Murdoch denied but the Columbia Journalism Review’s Emily Bell saw as quite sensible. Here at the Lab, Ken Doctor examined what a trust for those papers might look like.
— A couple of interesting pieces of survey data discussed this week: The study that drew most of the headlines was one that looked at the political knowledge of audiences for various news outlets, finding NPR’s listeners to be the most informed and Fox News’ viewers to be the least informed. Another study found that about half of media professionals abandon websites when they hit a paywall.
— Finally, a couple of cool pieces on data journalism — Simon Rogers of The Guardian urged us to take on the punk “anyone can do it” mindset toward data journalism, and Alex Howard of O’Reilly Radar talked with former Guardian digital editor Emily Bell about her efforts to put data journalism into action with students at Columbia University.
Similar posts: Synthroid Dosage. Cipro For Sale. Cipro Dosage. Cheap Zoloft. Generic Bactrim. Real brand Cipro online.
Trackbacks from: Cephalexin Dosage. Cephalexin Dosage. Cephalexin Dosage. Cephalexin from canada. Cephalexin wiki. No prescription Cephalexin online.
[This review was originally posted at the Nieman Journalism Lab Lipitor No Rx, on May 18, 2012.]
Facebook’s advertising uncertainties: This week’s biggest news is happening right now, as Facebook goes public after months of buildup. There were plenty of developments this week leading up to Facebook’s IPO, most of them not particularly good for Facebook. We’ll start with one positive piece of news: The company decided to make a last-minute increase in the size of its IPO, with 421 million shares offered to investors, making it the largest technology IPO ever. The change doesn’t affect Facebook’s overall valuation, Lipitor from canada, which is expected to be about $100 billion. NPR’s Planet Money questioned whether it’s really worth that much, concluding that it could only return that much value by undergoing an explosion in advertising revenue.
Slate’s Farhad Manjoo laid out the picture of how that ad blitz might begin, but Facebook’s inevitable ad ramp-up took a hit already this week when The Wall Street Journal reported that GM plans to pull all of its ads from Facebook, saying they just don’t work, Lipitor No Rx. Web marketer Rex Hammock noticed a couple of interesting points from the story: First, GM pays other companies three times what it spends on Facebook ads to market through Facebook’s “free” channels — Facebook-related marketing dollars that Facebook isn’t getting. Lipitor duration, Second, if GM is spending .05% of its ad budget on Facebook and thinks that’s too much, Facebook will have an extremely difficult time capturing a significant share of the overall ad market.
But All Things D’s Peter Kafka said there’s a lot of evidence GM’s social media marketing failure was GM’s, not Facebook’s, and argued that Facebook is big enough that it might not have to get advertising figured out to make gobs of money off of it. Forbes’ Jeff Bercovici and Robert Hof made similar points, generic Lipitor, with Bercovici noting that other automakers are doing just fine with Facebook ads and Hof saying companies have work to do in learning to adjust their marketing to social media.
Others put the onus on Facebook: Nate Elliot of Forrester said Facebook needs to take its features for marketers as seriously Lipitor No Rx, as it does its features for users. And tech investor Chris Dixon argued that Facebook is behind the eight-ball when it comes to advertising — while Google gets a lot of its ad revenue based on consumers who are already intending to buy something, Facebook users are generally just socializing. “You can put billboards all over a park, and maybe sometimes you’ll happen to convert people from non-purchasing to purchasing intents. But you end up with a cluttered park, Cheap Lipitor no rx, and not very effective advertising.” Like Dixon, GigaOM’s Mathew Ingram urged Facebook to diversify its revenue streams beyond advertising.
Meanwhile, an AP-CNBC poll revealed more trouble, finding that more than half of Facebook users don’t trust the company to keep their data private and wouldn’t feel safe conducting financial transactions there. SiliconBeat’s Chris O’Brien reflected on the idea that many Facebook users seem to cast themselves as the victims of its addictive powers rather than fans of the company. Interestingly, Twitter’s favorability numbers in the poll were even lower than Facebook’s, a finding Forbes’ Kashmir Hill tried to explain, Lipitor No Rx.
Matthew Panzarino of The Next Web explored the other side of this change: Every time Google gives you information directly, it’s not taking you to a page it’s indexed, but instead is acting as a content provider, rather than a conduit, buy Lipitor without a prescription. He compared it to the way Apple’s Siri relies on partnerships with Wolfram Alpha and Yelp to bypass Google, and said, “Google has begun the disintermediation of the web, but it’s starting small.” GigaOM’s Jeff John Roberts also saw in Knowledge Graph a bid to get users to spend more time on its own pages and fewer on other people’s, and PC Mag’s Mark Hachman looked at the feature as a response to a similar recent upgrade to Microsoft’s Bing.
Should everyone learn to code?: The movement to encourage average non-developers, particularly journalists, to learn to code has gained quite a bit of momentum over the past year or two, and a dissenting voice drew a lot of attention this week, Lipitor used for. Stack Exchange founder Jeff Atwood made the case against having non-professionals learn programming, arguing, among other things, that the “everyone should learn to code” movement “assumes that coding is the goal. Software developers tend to be software addicts who think their job is to write code, Lipitor No Rx. But it’s not. Their job is to solve problems.”
The post provoked a set of sharp responses from across the programming and developing communities. Discount Lipitor, If you want to dive deep into the discussion, you can check out this Y Combinator thread. Several others disagreed with Atwood’s point: One Github poster argued that Atwood falsely conflated learning to code for personal and professional reasons, and expounded on the value of learning to code as a form of digital literacy. Zed Shaw of Learn Code the Hard Way asserted that Atwood’s post was rooted in professional resentment of a flood of new coders.
Ilya Liechtenstein of MixRank explained Lipitor No Rx, how teaching herself to code helped give her insight into how the technical side of her startup works and what to work toward, and French designer Sacha Greif said learning to code is an extremely empowering exercise. App developer Gina Trapani did agree with one big part of Atwood’s post, affirming his argument that software development is about finding solutions, Lipitor brand name, not coding.
Twitter’s emailed digests: Twitter made a bit of news this week, too: It announced a new partnership with ESPN to create custom campaigns for various brands built around sporting events, and also announced that it’s allowing users to opt not be tracked. The announcement that got the most publicity, Lipitor pharmacy, though, was the launch of a new weekly “Best of Twitter” email sent to users.
TechCrunch’s Ryan Lawler wondered about whether the weekly email would outlast the shelf life of a tweet, though All Things D’s Mike Isaac countered that this could be a smart way to help teach newcomers how to navigate Twitter’s sometimes confusing interface and get the most out of the platform. Mathew Ingram of GigaOM said Twitter continues to toe the line between serving and competing with media companies, and AllTwitter’s Mary Long pointed out that we’re now seeing what Twitter did with Summify, the startup it bought in January, Lipitor No Rx.
More criminal charges for News Corp.: The investigation into News Corp.’s phone hacking scandal pushes on with one important development this week, as Rebekah Brooks, the former head of the company’s British newspaper division, Lipitor recreational, was charged with perverting the course of justice over allegations that she tried to hide evidence from investigators. Her husband and four others were also charged. The couple was defiant, with Charlie Brooks saying his wife was the “subject of a witch hunt.”
Before her charge came down, Brooks testified last Friday to the British government’s Leveson Inquiry, Order Lipitor no prescription, which was summarized well by The New York Times. Here in the States, Free Press’ Tim Karr criticized Congress and the FCC for not challenging News Corp., and the Times’ Ravi Somaiya gave a bird’s-eye view of the case.
Reading roundup Lipitor No Rx, : Here’s what else you might have missed in the past week:
— A couple of other important pieces of news from the newspaper industry: Just months after buying the Omaha World-Herald, Warren Buffett plunged a lot deeper into newspapers, buying 63 dailies and weeklies from Media General (Dan Conover has a sharp analysis), Lipitor from mexico, and former CBS digital head (and MarketWatch founder) Larry Kramer was named USA Today’s publisher. Poynter’s Andrew Beaujon looked back at Kramer’s past statements about how the newsroom should be rethought.
— ‘Tis the season of commencement speeches, and Andrew Beaujon chronicled the speeches given by journalists across the U.S., while Free Press’ Josh Stearns challenged Ted Koppel’s assertion in one of those speeches that Twitter is a neutral tool. Stearns also followed up with a critique of what he called Koppel’s concern with “hindsight journalism.”
— A few interesting or helpful pieces to leave you with: the AP's Jonathan Stray did some more thinking about the “solution journalism” concept — specifically, agreeing on the problems; media scholar Alfred Hermida talked to Craig Silverman about verification on Twitter; and Digital First’s Steve Buttry gave his guidelines for aggregation — link, attribute, and add value.
Similar posts: Cipro Over The Counter. Purchase Flagyl. Buy Bactrim No Prescription. About Glucophage. Where can i order Glucophage without prescription. Cipro brand name.
Trackbacks from: Lipitor No Rx. Lipitor No Rx. Lipitor No Rx. Lipitor steet value. Buy Lipitor without a prescription. Generic Lipitor.
[This review was originally posted at the Nieman Journalism Lab Diflucan Price, on February 3, 2012.]
Twitter spells out its censorship policy: Just a couple of weeks after the SOPA/PIPA fight came to a head, Twitter pushed the discussion about online censorship a bit further when it announced late last week a new policy for censoring tweets: When Twitter gets requests from governments to block tweets containing what they deem illegal speech, its new policy will allow it to block those tweets only to readers within that country, leaving it visible to the rest of the world. Twitter will send notice that it's blocked a tweet to the censorship watchdog Chilling Effects.
As the Guardian and the New York Times noted, much of the initial response among Twitter users consisted of complaints about censorship and the chilling of free speech in countries with oppressive regimes. The policy had critics elsewhere, too: BoingBoing's Xeni Jardin said "it's hard to see this as anything but a huge setback and disappointment," and the international group Reporters Without Borders sent an open letter to Twitter questioning the policy and urging the company to reconsider. And later, BoingBoing's Rob Beschizza pointed out that even though Twitter implied that it had already been blocking tweets at the request of governments (which would have made the new policy a reduction in censorship), it's never actually done so — only in response to legal challenges on copyright issues.
But perhaps surprisingly, Twitter had far more defenders than critics among media observers, Diflucan Price. Alex Howard of GovFresh put together the most comprehensive roundup of opinions on the subject, Diflucan from canadian pharmacy, praising Twitter himself for "sticking up for users where it can." Two free-speech advocates, Mike Masnick of TechDirt and the Electronic Frontier Foundation's Jillian York, made similar arguments: When a government is demanding censorship, Twitter can either refuse and be blocked entirely in that country, or it can comply. Twitter, they said, Diflucan photos, has chosen the latter in as limited and transparent fashion as possible.
Others, like The Next Web's Nancy Messieh, commended Twitter for shifting the censorship focus to the government — as Reuters' Paul Smalera argued, the gray box noting that a tweet has been censored in a certain country is a black mark for that government, Order Diflucan online c.o.d, not Twitter. The broadest argument in Twitter's defense came from sociologist Zeynep Tufekci, who, in addition to these arguments, also praised Twitter for its transparency and for allowing users an easy way to circumvent censorship. Diflucan Price, Still others weren't firmly on either side regarding the policy itself, but pointed to larger issues surrounding it. Media prof C.W. Anderson said that while Twitter did the best it could under the circumstances but showed it doesn't have any values that override its place as a business: "non-market values are, is Diflucan safe, in the long run, incompatible with the logic of the market, and what Twitter is trying to do now is reconcile what it believes with what the market needs it to do." Tech pioneer Dave Winer called for people to learn to be able to organize themselves outside of Twitter's infrastructure and the possibly of censorship.
In a pair of thoughtful posts, GigaOM's Mathew Ingram advised caution in trusting Twitter, Doses Diflucan work, recognizing that like Google and Facebook, it's a business whose interests might not align with our own. The EFF's York and Eva Galperin encouraged users and observers to keep a close eye on Twitter in order to keep them accountable for adhering to their professed beliefs.
Facebook goes public: Facebook's much-anticipated filing for a public stock offering came on Wednesday, and the New York Times and Danny Sullivan at Marketing Land have the best quick-hit summaries of the S-1 document, Diflucan Price. The big numbers are mind-bogglingly big: 845 million monthly active users, $5 billion in stock, $3.71 billion in revenue last year, $1 billion in profit, Diflucan trusted pharmacy reviews. Of that revenue, 85% came from advertising, and 12% came from the social gaming giant Zynga alone. (All Things D has the background on that relationship.) And when you average it out, Facebook's only getting $4.39 in revenue per active user. Diflucan dose, Aside from the numbers, among the other items of interest from the filings was its risk assessment — as summarized by Mashable, it sees slowing expected growth, difficulty in making money off of mobile access, competition from the likes of Google and Twitter, and global government censorship as some of its main risk factors. Diflucan Price, There's also Mark Zuckerberg's letter to shareholders, annotated with delightful snark by Wired's Tim Carmody, which includes the explanation of a company code Zuckerberg calls "The Hacker Way." Forbes' Andy Greenberg made one of the first of what's sure to be many comparisons between The Hacker Way and Google's "Don't Be Evil." GigaOM's Mathew Ingram took note of the grandiosity of Zuckerberg's stated mission to rewire the world.
Two main questions emerged in commentary on the filing: How much is Facebook really worth, Diflucan blogs. And what happens to Facebook now. To the first question, as the New York Times pointed out on the eve of Facebook's filing, the company's massive net worth is a stark indicator of the booming value of personal data collected online. The Columbia Journalism Review's Ryan Chittum took the opposite tack, Diflucan duration, wondering why Facebook gets so little money out of each of its hundreds of millions of users before concluding that "Facebook is still a young business figuring out how to sell ads and figuring it how aggressive it can get without ticking off users."
To the second question, Mathew Ingram noted that going public is usually a way for tech companies to get the financing they need to build up for some major growth — something Facebook has already done. So, he asked, is this just an attempt for Facebook's employees and backers to cash out, and the end of the company's most productive growth phase, Diflucan Price. Leaning on tech entrepreneurship leader John Battelle, Wired's Tim Carmody and Mike Isaac reasoned that Facebook is mature enough already that in order to attain the growth it's promising, it needs to be in the midst of some massive changes as a company. A couple of guesses at some of those specific changes: More ads and purchases of tech companies (Fast Company) and a big ramp-up in mobile ads (Marketing Land).
Murdoch's candor amid scandal: The phone-hacking scandal at Rupert Murdoch's News Corp, Diflucan dosage. has continued to spread (rather quietly here in the States, but much more prominently in the U.K.), and it may have turned yet another corner with the arrest last weekend of four journalists from News Corp.'s Sun, significantly deepening the scandal beyond the now-defunct News of the World, where it began. Diflucan Price, News Corp. Is Diflucan addictive, has also turned over an enormous new trove of data which, along with the arrests, could begin to seriously threaten News Corp.'s other British newspapers, including the Times, according to the Guardian's Nick Davies. British j-prof Roy Greenslade reported that many Sun staffers are worried that they may not be part of News Corp. much longer, Diflucan overnight.
In the midst of all this, Murdoch's feisty Twitter account continues unfettered, prompting praise from the New York Times' David Carr for his refreshing candor. Mathew Ingram agreed that this "sources go direct" approach should be viewed as a boon, not a challenge, to serious journalism, Diflucan Price. The AP's Jonathan Stray had perhaps the best summation of the relationship between sources using their own platforms and journalism: "When they want you to know, sources will go direct. After Diflucan, When they don't... that's journalism."
Reading roundup: It was a relatively quiet week outside of the big Twitter and Facebook stories, but there were still some cool nuggets to be found:
— Facebook's relatively new Twitter-like Subscribe feature continues to draw complaints of rampant spam. Those criticisms have been led by Jim Romenesko, but this week the New York Daily News and Slate's Katherine Goldstein chimed in, voicing concerns in particular about inappropriate comments directed toward women. Diflucan Price, Meanwhile, Mashable's Todd Wasserman said Subscribe is ruining the News Feed.
— Big news in the journalism-academy world: Columbia and Stanford are teaming up to create a new Institute for Media Innovation, Diflucan forum, thanks to a $30 million gift from longtime Cosmopolitan editor Helen Gurley Brown.
— Jay Rosen posted an inspiring interview with the Chicago Tribune's Tracy Samantha Schmidt, gleaning some useful insights on how to nurture an innovative and entrepreneurial spirit within a large organization, rather than a startup.
— Megan Garber of the Atlantic presented the results of a Hot or Not-style study that determined what type of Twitter content people like. Here's what they don't like: Old news, Twitter jargon, personal details, negativity, and lack of context.
Similar posts: Glucophage No Rx. Cephalexin Price. Glucophage For Sale. Herbal Tramadol. Cephalexin interactions. Cephalexin overnight.
Trackbacks from: Diflucan Price. Diflucan Price. Diflucan Price. Japan, craiglist, ebay, overseas, paypal. Order Diflucan from United States pharmacy. Diflucan no rx.